HOME › DRUGS › BROLUCIZUMAB-DBLL
ACTIVE SUBSTANCE / INN

BROLUCIZUMAB-DBLL

Brand name(s): BEOVU
FDA LISTED
PRESCRIPTION
BLA761125
ACTIVE SUBSTANCE
Brolucizumab-Dbll
REGULATORS
FDA
SPONSORS / MAH
NOVARTIS PHARMS CORP
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BEOVUBLA761125NOVARTIS PHARMS CORPPrescription

FULL INTELLIGENCE ON BROLUCIZUMAB-DBLL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →